Spots Global Cancer Trial Database for antineoplastic agents, alkylating

Every month we try and update this database with for antineoplastic agents, alkylating cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Natural Killer Cell (CYNK-001) Infusions in Adults With AML	NCT04310592	Leukemia Leukemia, Myelo... Leukemia, Myelo... Neoplasms by Hi... Neoplasms Immunosuppressi... Immunologic Fac... Physiological E... Alkylating Agen... Antimetabolites... Antiviral Agent... Analgesics, Non... Anti-infective ... Analgesics Peripheral Nerv... Hematologic Dis... Hematologic Neo... Leukemia in Rem... Relapsed Adult ... Refractory AML	CYNK-001	18 Years - 80 Years	Celularity Incorporated
Randomized Study of Combination Chemotherapy With or Without Focused Microwave Thermotherapy Before Surgery in Treating Women With Large Breast Cancer Tumors	NCT01204801	Breast Cancer	Focused Microwa... Chemotherapy (c...	18 Years -	Medifocus, Inc.
Trial of GVHD Prophylasxis With PTCy or Thymoglobulin in Unrelated SCT	NCT02627573	Leukemia, Chron... Myelodysplastic... Leukemia, Myelo...	Unrelated allog... Busulfan Fludarabine mon... Tacrolimus Mycophenolate m... Cyclophosphamid... Thymoglobulin	18 Years - 75 Years	St. Petersburg State Pavlov Medical University
Post-transplantation Cyclophosphamide as GVHD Prophylaxis After HSCT	NCT02294552	Acute Myeloid L... Acute Lymphoid ... Lymphoma Myelodysplastic... Chronic Lymphoc... Immune System D...	Cyclophosphamid... Busulfan Fludarabine mon... Tacrolimus Mycophenolate m... Allogeneic hema...	18 Years - 65 Years	St. Petersburg State Pavlov Medical University
GVHD Prophylaxis With Post-transplantation Bendamustine in Refractory Leukemia	NCT02799147	Leukemia, Acute... Acute Myeloid L... Mixed-Lineage A...	Allogeneic stem... Fludarabine mon... Busulfan Bendamustine	18 Years - 60 Years	St. Petersburg State Pavlov Medical University
Randomized Study of Combination Chemotherapy With or Without Focused Microwave Thermotherapy Before Surgery in Treating Women With Large Breast Cancer Tumors	NCT01204801	Breast Cancer	Focused Microwa... Chemotherapy (c...	18 Years -	Medifocus, Inc.
Benadamustine, Fludarabine and Busulfan Conditioning in Recipients of Haploidentical Stem Cell Transplantation (FluBuBe)	NCT04942730	Leukemia, Acute... Myeloid Leukemi... Biphenotypic Ac... Lymphoblastic L... Myelodysplastic... Myeloproliferat...	Fludarabine Bendamustine Hy... Busulfan Cyclophosphamid... Mycophenolate M... Tacrolimus 5Mg ...	18 Years - 75 Years	St. Petersburg State Pavlov Medical University
SGN-30 and Combination Chemotherapy in Treating Patients With Newly Diagnosed Anaplastic Large Cell Lymphoma	NCT00365274	Anaplastic Larg...	Cyclophosphamid... Doxorubicin hyd... vincristine sul... prednisone SGN-30	18 Years -	National Cancer Institute (NCI)
Natural Killer Cell (CYNK-001) Infusions in Adults With AML	NCT04310592	Leukemia Leukemia, Myelo... Leukemia, Myelo... Neoplasms by Hi... Neoplasms Immunosuppressi... Immunologic Fac... Physiological E... Alkylating Agen... Antimetabolites... Antiviral Agent... Analgesics, Non... Anti-infective ... Analgesics Peripheral Nerv... Hematologic Dis... Hematologic Neo... Leukemia in Rem... Relapsed Adult ... Refractory AML	CYNK-001	18 Years - 80 Years	Celularity Incorporated

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: